Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved two new indications for Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in ...
Indian CROs well integrated with electronic systems as US FDA issues new guidelines regarding electronic records: Nandita Vijayasimha, Bengaluru Friday, October 25, 2024, 08:00 Hr ...
Delhi HC refuses Abbott's appeal in trade mark dispute on pain killer drug Mebufen: Gireesh Babu, New Delhi Friday, October 25, 2024, 08:00 Hrs [IST] The Delhi High Court has orde ...
PCI requests all pharmacy institutions to register with NAD/ABC: Our Bureau, New Delhi Friday, October 25, 2024, 08:00 Hrs ...
Pharmexcil calls on members to enroll as voters for 2024-26 elections: Shardul Nautiyal, Mumbai Friday, October 25, 2024, 08:00 Hrs [IST] The Pharmaceuticals Export Promotion Coun ...
Repare Therapeutics reports updated positive safety and tolerability results from phase 1 MYTHIC trial: Cambridge, Massachusetts Thursday, October 24, 2024, 18:00 Hrs [IST] Repare ...
Strides in Q2FY25 reports revenues Rs. 1,201.1 crore up 17% PAT Rs. 93.7 crore: Our Bureau, Bengaluru Thursday, October 24, 2024, 17:10 Hrs [IST] Strides Pharma Science in its Q2 ...
AIRS Medical & HealthCare Konnect partner to revolutionize MRI efficiency in Switzerland with SwiftMR: Seoul, Republic of Korea Thursday, October 24, 2024, 17:00 Hrs [IST] AIRS Me ...
Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the ...